Acumen Pharmaceuticals Inc’s (NASDAQ: ABOS) Stock Falls -0.32 Percent, But Further Downside Could Be On The Way
Acumen Pharmaceuticals Inc (NASDAQ:ABOS)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 0.21. At the close of